Natalie Fuchs
8PUBLICATIONS
27CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Nov 20, 2024
From Virtual Screens to Cellular Target Engagement: New Small Molecule Ligands for the Immune Checkpoint LAG-3.Natalie Fuchs, Laura Calvo-Barreiro, Valerij Talagayev
|Jun 19, 2024
Structural Modifications of Covalent Cathepsin S Inhibitors: Impact on Affinity, Selectivity, and Permeability.Mergim Meta, Collin Zimmer, Natalie Fuchs
|Apr 30, 2024
Dual Strategy to Design New Agents Targeting <i>Schistosoma mansoni</i>: Advancing Phenotypic and <i>Sm</i>CB1 Inhibitors for Improved Efficacy.Natalie Fuchs, Robert A Zimmermann, Marvin Schwickert
|Jan 22, 2024
Inhibitors of Immune Checkpoints: Small Molecule- and Peptide-Based Approaches.Natalie Fuchs, Longfei Zhang, Laura Calvo-Barreiro
|Jun 14, 2023
Next Generation of Fluorometric Protease Assays: 7-Nitrobenz-2-oxa-1,3-diazol-4-yl-amides (NBD-Amides) as Class-Spanning Protease Substrates.Hannah Maus, Patrick Müller, Mergim Meta
|May 24, 2023
Subnanomolar Cathepsin S Inhibitors with High Selectivity: Optimizing Covalent Reversible α-Fluorovinylsulfones and α-Sulfonates as Potential Immunomodulators in Cancer.Natalie Fuchs, Mergim Meta, Bellinda Lantzberg
Pageof 2
Frequent Collaborators
4 joint publications
Mergim Meta
2 joint publications
Moustafa T Gabr
2 joint publications
Robert A Zimmermann
2 joint publications
Tanja Schirmeister
1 joint publications
Gerhard Wolber
1 joint publications
Stefan Tenzer
1 joint publications
Ute Distler
1 joint publications
Hans-Joachim Räder
1 joint publications
Bernd Engels
1 joint publications
Stephan Brinkmann
